The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
Open accessAbstract
Obesity is a growing worldwide health problem, affecting many people due to excessive saturated fat consumption, lack of exercise, or a sedentary lifestyle. Leptin is an adipokine secreted by adipose tissue that increases in obesity and has central actions not only at the hypothalamic level but also in other regions and nuclei of the central nervous system (CNS) such as the cerebral cortex and hippocampus. These regions express the long form of leptin receptor LepRb, which is the unique leptin receptor capable of transmitting complete leptin signaling, and are the first regions to be affected by chronic neurocognitive deficits, such as mild cognitive impairment (MCI) and Alzheimer’s Disease (AD). In this review, we discuss different leptin resistance mechanisms that could be implicated in increasing the risk of developing AD, as leptin resistance is frequently associated with obesity, which is a chronic low-grade inflammatory state, and obesity is considered a risk factor for AD. Key players of leptin resistance are SOCS3, PTP1B, and TCPTP whose signalling is related to inflammation and could be worsened in AD. However, some data are controversial, and it is necessary to further investigate the underlying mechanisms of the AD-causing pathological processes and how altered leptin signalling affects such processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The AD risk is greatly increased by the APOE ε4 allele.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [44]
In the citing paper
“A person with one copy of this allele is more likely to be affected than a person with two copies [42,43,44].”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Marwarha, G., Raza, S., Meiers, C., & Ghribi, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.015 · Cited by 107
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Neuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
Identification of SOCS-3 as a Potential Mediator of Central Leptin Resistance
Bjørbæk, C., Elmquist, J. K., Frantz, J. D., Shoelson, S. E., & Flier, J. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80062-3 · Cited by 1,014
Activation of Downstream Signals by the Long Form of the Leptin Receptor
Banks, A. S., Davis, S. M., Bates, S. H., & Myers, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14563 · Cited by 797
Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects.
Sinha, M. K., Ohannesian, J. P., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Magosin, S., Marco, C. C., & Caro, J. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118551 · Cited by 780
Raji, C. A., Ho, A. J., Parikshak, N., Becker, J. T., López, O. L., Kuller, L. H., Hua, X., Leow, A., Toga, A. W., & Thompson, P. M. (2009) · Human Brain Mapping · doi:10.1002/hbm.20870 · Cited by 685
Elevated body mass index is associated with executive dysfunction in otherwise healthy adults
Gunstad, J., Paul, R. H., Cohen, R. A., Tate, D. F., Spitznagel, M. B., & Gordon, E. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2006.05.001 · Cited by 668
Cognitive impairment following high fat diet consumption is associated with brain inflammation
Pistell, P. J., Morrison, C. D., Gupta, S., Knight, A. G., Keller, J. N., Ingram, D. K., & Bruce‐Keller, A. J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.010 · Cited by 623
Human Leptin Stimulates Proliferation and Activation of Human Circulating Monocytes
Santos‐Álvarez, J., Goberna, R., & Sánchez‐Margalet, V. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1490 · Cited by 613
Self-citationObesity-Induced Neuroinflammation: Beyond the Hypothalamus
Guillemot‐Legris, O., & Muccioli, G. G. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.02.005 · Cited by 593
Human Leptin Enhances Activation and Proliferation of Human Circulating T Lymphocytes
Martín-Romero, C., Santos‐Álvarez, J., Goberna, R., & Sánchez‐Margalet, V. (2000) · Cellular Immunology · doi:10.1006/cimm.1999.1594 · Cited by 527
Self-citationLeptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later
Izquierdo, A. G., Crujeiras, A. B., Casanueva, F. F., & Carreira, M. C. (2019) · Nutrients · doi:10.3390/nu11112704 · Cited by 525
Brain abnormalities in human obesity: A voxel-based morphometric study
Pannacciulli, N., Del Parigi, A., Chen, K., Le, D. S. N. T., Reiman, E. M., & Tataranni, P. A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.047 · Cited by 523
Kennedy, A., Gettys, T. W., Watson, P. M., Wallace, P., Ganaway, E., Qin, P., & Garvey, W. T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.4.3859 · Cited by 508
BMI and risk of dementia in two million people over two decades: a retrospective cohort study
Qizilbash, N., Gregson, J., Johnson, M. E., Pearce, N. E., Douglas, I., Wing, K., Evans, S. J. W., & Pocock, S. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00033-9 · Cited by 477
Leptin Receptor Signaling and the Regulation of Mammalian Physiology
Myers, M. G. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.287 · Cited by 463
Leptin resistance and diet-induced obesity: central and peripheral actions of leptin
Sáinź, N., Barrenetxe, J., Moreno-Aliaga, M. J., & Martínez, J. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.015 · Cited by 441
Role of Leptin in the Activation of Immune Cells
Riejos, P. F., Najib, S., Santos‐Álvarez, J., Martín-Romero, C., Pérez‐Pérez, A., González-Yanes, C., & Sánchez‐Margalet, V. (2010) · Mediators of Inflammation · doi:10.1155/2010/568343 · Cited by 439
Self-citationRole of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action
Sánchez‐Margalet, V., Martín-Romero, C., Santos‐Álvarez, J., Goberna, R., Najib, S., & González-Yanes, C. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02190.x · Cited by 364
Self-citationLeptin resistance: underlying mechanisms and diagnosis
Gruzdeva, O. V., Borodkinа, D. A., Учасова, Е. Г., Dyleva, Y. A., & Барбараш, О. Л. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s182406 · Cited by 331
Role of Leptin in Inflammation and Vice Versa
Pérez-Pérez, A., Sánchez-Jiménez, F., Vilariño-García, T., & Sánchez-Margalet, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165887 · Cited by 330
Self-citationThe Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
Forny‐Germano, L., Felice, F. G. D., & Vieira, M. N. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01027 · Cited by 304
2003-2013: A Decade of Body Mass Index, Alzheimer's Disease, and Dementia
Emmerzaal, T. L., Kiliaan, A. J., & Gustafson, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141086 · Cited by 303
Adipokines: a link between obesity and dementia?
Kiliaan, A. J., Arnoldussen, I. A. C., & Gustafson, D. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70085-7 · Cited by 290
High fat diet induces brain insulin resistance and cognitive impairment in mice
Kothari, V. M., Luo, Y., Tornabene, T., O’Neill, A. M., Greene, M. W., Geetha, T., & Babu, J. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.006 · Cited by 290
Role of leptin as a link between metabolism and the immune system
Pérez‐Pérez, A., Vilariño‐García, T., Riejos, P. F., Martín-González, J., Segura-Egea, J. J., & Sánchez‐Margalet, V. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.001 · Cited by 281
Self-citationRole of metabolism in neurodegenerative disorders
Procaccini, C., Santopaolo, M., Faicchia, D., Colamatteo, A., Formisano, L., de Candia, P., Galgani, M., De Rosa, V., & Matarese, G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.018 · Cited by 258
Studies of the effects of high fat diets on cognitive function in a rat model
Winocur, G., & Greenwood, C. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.003 · Cited by 250
Overview of Adipose Tissue and Its Role in Obesity and Metabolic Disorders
Frühbeck, G. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-245-8_1 · Cited by 233
Leptin treatment: Facts and expectations
Paz-Filho, G., Mastronardi, C. A., & Licinio, J. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.014 · Cited by 229
Obesity and dementia: Adipokines interact with the brain
Arnoldussen, I. A. C., Kiliaan, A. J., & Gustafson, D. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.002 · Cited by 226
Srivastava, P., Tripathi, P. N., Sharma, P. A., Nand, S., Singh, S. P., Srivastava, R. K., Shankar, S., & Shrivastava, S. K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.049 · Cited by 220
Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease
Nand, S., Singh, C., Singh, A., Singh, M. P., & Singh, S. P. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01945-y · Cited by 215
Tripathi, P. N., Srivastava, P., Sharma, P. A., Tripathi, M. K., Seth, A., Tripathi, A., Nand, S., Singh, S. P., & Shrivastava, S. K. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.12.017 · Cited by 210
Wang, R., Li, J. J., Diao, S., Kwak, Y.-D., Liu, L., Zhi, L., Büeler, H., Bhat, N. R., Williams, R. W., Park, E. A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.016 · Cited by 199
Yokum, S., Ng, J., & Stice, E. M. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.175 · Cited by 197
Cavaliere, G., Trinchese, G., Penna, E., Cimmino, F., Pirozzi, C., Lama, A., Annunziata, C., Catapano, A., Raso, G. M., Meli, R., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00509 · Cited by 191
Parimisetty, A., Dorsemans, A.-C., Awada, R., Ravanan, P., Diotel, N., & Lefebvre d’Hellencourt, C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0530-x · Cited by 188
Protein Tyrosine Phosphatases in Hypothalamic Insulin and Leptin Signaling
Zhang, Z., Dodd, G. T., & Tiganis, T. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.003 · Cited by 185
Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor
Carpenter, L. R., Farruggella, T. J., Symes, A. J., Karow, M. L., Yancopoulos, G. D., & Stahl, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6061 · Cited by 176
Gong, Y., Ishida-Takahashi, R., Villanueva, E. C., Fingar, D. C., Münzberg, H., & Myers, M. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702838200 · Cited by 173
The blood–brain barrier as an endocrine tissue
Banks, W. A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0213-7 · Cited by 168
Midlife adiposity and the future risk of Parkinson’s disease
Abbott, R. D., Ross, G. W., White, L. R., Nelson, J. S., Masaki, K., Tanner, C. M., Curb, J. D., Blanchette, P. L., Popper, J. S., & Petrovitch, H. (2002) · Neurology · doi:10.1212/wnl.59.7.1051 · Cited by 163
Blood-Brain Barriers in Obesity
Rhea, E. M., Salameh, T. S., Logsdon, A. F., Hanson, A. J., Erickson, M. A., & Banks, W. A. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0079-3 · Cited by 162
Sobesky, J. L., Barrientos, R. M., May, H. S. D., Thompson, B. M., Weber, M. D., Watkins, L. R., & Maier, S. F. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.017 · Cited by 160
Wada, N., Hirako, S., Takenoya, F., Kageyama, H., Okabe, M., & Shioda, S. (2014) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2014.09.002 · Cited by 156
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance
Bonda, D., Stone, J. G., Torres, S. L., Siedlak, S. L., Perry, G. L., Kryscio, R. J., Jicha, G. A., Casadesús, G., Smith, M. A., Zhu, X., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12380 · Cited by 150
Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease
Kang, S., Lee, Y., & Lee, J. E. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.3.479 · Cited by 147
Associations between obesity and cognitive impairment in the Chinese elderly: an observational study
Hou, Q., Yang, G., Yu, W., Liu, X., Wu, L., Xiao, M., & Lü, Y. (2019) · Clinical Interventions in Aging · doi:10.2147/cia.s192050 · Cited by 138
Krishnan, N., Konidaris, K. F., Gasser, G., & Tonks, N. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.c117.819110 · Cited by 134
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Vieira, M. N. N., Lima‐Filho, R. A. S., & Felice, F. G. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.014 · Cited by 133
Leptin Dysfunction and Alzheimer’s Disease: Evidence from Cellular, Animal, and Human Studies
McGuire, M. J., & Ishii, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0282-7 · Cited by 129
Sah, S. K., Lee, C. M., Jang, J., & Park, G. H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.122 · Cited by 126
Mammalian Target of Rapamycin (mTor) Mediates Tau Protein Dyshomeostasis
Tang, Z., Bereczki, E., Zhang, H., Wang, S., Li, C., Ji, X., Branca, R. M., Lehtiö, J., Guan, Z., Filipčík, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435123 · Cited by 124
Frontal cortical thinning and subcortical volume reductions in early adulthood obesity
Marqués‐Iturria, I., Pueyo, R., Garolera, M., Segura, B., Junqué, C., García‐García, I., Palacios, M. J. S., Vernet‐Vernet, M., Narberhaus, A., Ariza, M., et al. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.06.004 · Cited by 123
Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
Vieira, M. N. N., Silva, N. M. L. E., Ferreira, S. T., & Felice, F. G. D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00007 · Cited by 123
Reduced cortical thickness associated with visceral fat and BMI
Veit, R., Kullmann, S., Heni, M., Machann, J., Häring, H., Fritsche, A., & Preissl, H. T. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.09.013 · Cited by 112
Ishii, M., Wang, G., Racchumi, G., Dyke, J. P., & Iadecola, C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0872-14.2014 · Cited by 109
Pedroso, J. A. B., Buonfiglio, D. D. C., Cardinali, L. I., Furigo, I. C., Ramos-Lobo, A. M., Tirapegui, J., Elias, C. F., & Donato, J. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.06.001 · Cited by 106
SOCS3 as a future target to treat metabolic disorders
Pedroso, J. A. B., Ramos-Lobo, A. M., & Donato, J. (2018) · HORMONES · doi:10.1007/s42000-018-0078-5 · Cited by 106
Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition
Kaneko, K., Fu, Y., Lin, H.-Y., Cordonier, E. L., Mo, Q., Gao, Y., Yao, T., Naylor, J., Howard, V., Saito, K., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126107 · Cited by 106
Wu, Y., Yu, Y., Szabo, A., Han, M., & Huang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092618 · Cited by 105
The LepR-mediated leptin transport across brain barriers controls food reward
Spiezio, A. D., Sandin, E. S., Dore, R., Müller‐Fielitz, H., Storck, S. E., Bernau, M., Mier, W., Oster, H., Jöhren, O., Pietrzik, C. U., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.001 · Cited by 103
Fluorescent blood–brain barrier tracing shows intact leptin transport in obese mice
Harrison, L. P., Schriever, S. C., Feuchtinger, A., Kyriakou, E., Baumann, P., Pfuhlmann, K., Messias, A. C., Walch, A. K., Tschöp, M. H., & Pfluger, P. T. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0221-z · Cited by 100
Dodd, G. T., Xirouchaki, C. E., Eramo, M. J., Mitchell, C. A., Andrews, Z. B., Henry, B. A., Cowley, M. A., & Tiganis, T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.019 · Cited by 95
Is Alzheimer’s disease an inflammasomopathy?
Pereira, C., Santos, A. E., Moreira, P. I., Pereira, A. C., Sousa, F. J., Cardoso, S. M., & Cruz, M. T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100966 · Cited by 95
Obesity as a Risk Factor for Alzheimer’s Disease: Implication of Leptin and Glutamate
Lloret, A., Monllor, P., Esteve, D., Cervera‐Ferri, A., & Lloret, M.-Á. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00508 · Cited by 94
Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents – A brief review
Verma, M., Gupta, S. J., Chaudhary, A., & Garg, V. K. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.12.004 · Cited by 93
Greco, S. J., Hamzelou, A., Johnston, J. M., Smith, M. A., Ashford, J. W., & Tezapsidis, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.050 · Cited by 92
Ptacek, S. G., Irving, G. F., Čermáková, P., Eriksdotter, M., & Religa, D. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.199 · Cited by 91
Hakim, F., Wang, Y., Carreras, A., Hirotsu, C., Zhang, J., Peris, E., & Gozal, D. (2015) · Sleep · doi:10.5665/sleep.4320 · Cited by 90
The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis
Vamanu, E., & Nand, S. (2021) · Diseases · doi:10.3390/diseases9030045 · Cited by 90
Liu, Z., Gan, L., Zhou, Z., Jin, W., & Sun, C. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.02.004 · Cited by 85
Energy balance in early-stage Huntington disease
Gaba, A., Zhang, K., Marder, K. S., Moskowitz, C. B., Werner, P., & Boozer, C. N. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.6.1335 · Cited by 84
Protein Tyrosine Phosphatase 1B
Cook, W. S., & Unger, R. H. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00158-2 · Cited by 84
Neuroprotective effects of leptin in the context of obesity and metabolic disorders
Davis, C., Mudd, J., & Hawkins, M. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.012 · Cited by 84
Abdominal obesity and lower gray matter volume: a Mendelian randomization study
Debette, S., Wolf, C., Lambert, J., Crivello, F., Soumaré, A., Zhu, Y., Schilling, S., Dufouil, C., Mazoyer, B. M., Amouyel, P., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.022 · Cited by 82
Crispino, M., Trinchese, G., Penna, E., Cimmino, F., Catapano, A., Villano, I., Perrone‐Capano, C., & Mollica, M. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175964 · Cited by 81
Yam, K. Y., Naninck, E. F. G., Abbink, M. R., la Fleur, S. E., Schipper, L., van den Beukel, J. C., Grefhorst, A., Oosting, A., van der Beek, E. M., Lucassen, P. J., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.12.012 · Cited by 78
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 77
Maioli, S., Lodeiro, M., Merino‐Serrais, P., Falahati, F., Khan, W., Puerta, E., Codita, A., Rimondini, R., Ramírez, M. J., Simmons, A., et al. (2014) · Aging Cell · doi:10.1111/acel.12281 · Cited by 75
Hypothalamic ER stress: A bridge between leptin resistance and obesity
Ramírez, S., & Claret, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.025 · Cited by 75
Nordestgaard, L. T., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00195 · Cited by 74
New Pharmacological Perspectives for the Leptin Receptor in the Treatment of Obesity
Roujeau, C., Jockers, R., & Dam, J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00167 · Cited by 71
Modulation of leptin resistance by food compounds
Aragonès, G., Ardid‐Ruiz, A., Ibars, M., Suárez, M., & Bladé, C. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500964 · Cited by 69
McGregor, G., & Harvey, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00340 · Cited by 67
Changes in Leptin Signaling by SOCS3 Modulate Fasting-Induced Hyperphagia and Weight Regain in Mice
Pedroso, J. A. B., Silveira, M. A., Lima, L. B., Furigo, I. C., Zampieri, T. T., Ramos-Lobo, A. M., Buonfiglio, D. D. C., Teixeira, P. D. S., Frazão, R., & Donato, J. (2016) · Endocrinology · doi:10.1210/en.2016-1038 · Cited by 66
Johnston, J. M., Hu, W. T., Fardo, D. W., Greco, S. J., Perry, G. L., Montine, T. J., Trojanowski, J. Q., Shaw, L. M. J., Ashford, J. W., & Tezapsidis, N. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131212114156 · Cited by 64
Ishii, M., & Iadecola, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.029 · Cited by 63
Ozek, C., Kanoski, S. E., Zhang, Z., Grill, H. J., & Bence, K. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603621 · Cited by 62
Hypothalamic PKA regulates leptin sensitivity and adiposity
Yang, L., & McKnight, G. S. (2015) · Nature Communications · doi:10.1038/ncomms9237 · Cited by 61
Jiang, J., Wang, Z.-H., Qu, M., Gao, D., Liu, X.-P., Zhu, L., & Wang, J. (2015) · Scientific Reports · doi:10.1038/srep11765 · Cited by 57
Leptin activates AMP-activated protein kinase in hepatic cells via a JAK2-dependent pathway
Uotani, S., Abe, T., & Yamaguchi, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.015 · Cited by 56
Inflammatory Mediators as Biomarkers in Brain Disorders
Nuzzo, D., Picone, P., Caruana, L., Vasto, S., Barera, A., Caruso, C., & Carlo, M. D. (2013) · Inflammation · doi:10.1007/s10753-013-9780-2 · Cited by 56
The Effects of Leptin on Glial Cells in Neurological Diseases
Fujita, Y., & Yamashita, T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00828 · Cited by 54
Leptin in normal physiology and leptin resistance
Li, S., & Li, X. (2015) · 中国科学通报:英文版 · doi:10.1007/s11434-015-0951-4 · Cited by 52
Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease
Mejido, D. C. P., Peny, J. A., Vieira, M. N. N., Ferreira, S. T., & Felice, F. G. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108115 · Cited by 52
Ivanova, N., Liu, Q., Agca, C., Ağca, Y., Noble, E. G., Whitehead, S. N., & Cechetto, D. F. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1698-7 · Cited by 51
Serum Leptin is not Altered nor Related to Cognitive Decline in Alzheimer's Disease
Teunissen, C., van der Flier, W. M., Scheltens, P., Duits, A., Wijnstok, N., Nijpels, G., Dekker, J., Blankenstein, M., & Heijboer, A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141503 · Cited by 50
Alosco, M. L., Spitznagel, M. B., Strain, G. W., Devlin, M. J., Cohen, R. A., Crosby, R. D., Mitchell, J. E., & Gunstad, J. (2015) · Journal of Clinical Neurology · doi:10.3988/jcn.2015.11.1.48 · Cited by 50
Beyer, F., Masouleh, S. K., Kratzsch, J., Schroeter, M. L., Röhr, S., Riedel-Heller, S. G., Villringer, A., & Witte, A. V. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00202 · Cited by 49
Folch, J., Patraca, I., Martínez, N., Pedrós, I., Petrov, D., Ettcheto, M., Abad, S., Marin, M., Beas-Zarate, C., & Camins, A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.002 · Cited by 48
Overweight is not associated with cortical thickness alterations in children
Sharkey, R. J., Karama, S., & Dagher, A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00024 · Cited by 48
Improved metabolic phenotype of hypothalamic PTP1B-deficiency is dependent upon the leptin receptor
Tsou, R. C., Rak, K. S., Zimmer, D. J., & Bence, K. K. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.008 · Cited by 46
Yeh, S. H., Shie, F., Liu, H., Yao, H.-H., Kao, P.-C., Lee, Y.-H., Chen, L.-M., Hsu, S.-M., Chao, L.-J., Wu, K.-W., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.11.018 · Cited by 46
Leptin, neuroinflammation and obesity
Dragano, N. R. V., Haddad-Tovolli, R., & Velloso, L. A. (2017) · Frontiers of hormone research · doi:10.1159/000452908 · Cited by 45
Microglia, neurodegeneration and loss of neuroendocrine control
Chowen, J. A., & García‐Segura, L. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101720 · Cited by 45
Rai, Y., Anita, A., Kumari, N., Singh, S., Kalra, N., Soni, R., & Bhatt, A. N. (2020) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2020.148325 · Cited by 45
Ardid‐Ruiz, A., Harazin, A., Barna, L., Walter, F. R., Bladé, C., Suárez, M., Deli, M. A., & Aragonès, G. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112253 · Cited by 43
Hypothalamic inflammation and the central nervous system control of energy homeostasis
Pimentel, G. D., Ganeshan, K., & Carvalheira, J. B. C. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.005 · Cited by 42
Food for thought: Leptin regulation of hippocampal function and its role in Alzheimer's disease
McGregor, G., & Harvey, J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.038 · Cited by 42
Bradfield, N. I., & Ames, D. J. (2019) · BJPsych Bulletin · doi:10.1192/bjb.2019.77 · Cited by 42
Tsai, C., Pan, C., Chen, F., Huang, T., Tsai, M., & Chuang, C. (2019) · Experimental Physiology · doi:10.1113/ep087862 · Cited by 41
Plasma leptin levels and free leptin index in women with Alzheimer's disease
Baranowska-Bik, A., Bik, W., Styczyńska, M., Chodakowska-Żebrowska, M., Barcikowska, M., Wolińska‐Witort, E., Kalisz, M., Martyńska, L., & Baranowska, B. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.05.006 · Cited by 39
Nakata, M., Yamamoto, S., Okada, T., Gantulga, D., Okano, H., Ozawa, K., & Yada, T. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.201 · Cited by 39
Novel Insights into How Overnutrition Disrupts the Hypothalamic Actions of Leptin
Fruhwürth, S., Vogel, H., Schürmann, A., & Williams, K. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00089 · Cited by 38
Lee, Y.-H., Hsu, H.-C., Kao, P.-C., Shiao, Y., Yeh, S. H., Shie, F., Hsu, S.-M., Yeh, C.-W., Liu, H., Yang, S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082333 · Cited by 37
Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice
Meakin, P. J., Jalicy, S. M., Montagut, G., Allsop, D. J. P., Cavellini, D. L., Irvine, S. W., McGinley, C., Liddell, M. K., McNeilly, A. D., Parmionova, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18388-6 · Cited by 36
Ito, M., Fukuda, S., Sakata, S., Morinaga, H., & Ohta, T. (2014) · Journal of Diabetes Research · doi:10.1155/2014/680348 · Cited by 34
Christensen, A., & Pike, C. J. (2018) · The FASEB Journal · doi:10.1096/fj.201801756r · Cited by 31
The Effects of Leptin Replacement on Neural Plasticity
Paz-Filho, G. (2016) · Neural Plasticity · doi:10.1155/2016/8528934 · Cited by 30
Obesity and neuroinflammatory phenotype in mice lacking endothelial megalin
Bartolomé, F. B., Antequera, D., Tavares, E., Pascual, C., Maldonado, R., Camins, A., & Carro, E. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0800-2 · Cited by 30
Ginsenoside Rb1 improves leptin sensitivity in the prefrontal cortex in obese mice
Wu, Y., Huang, X., Bell, C., & Yu, Y. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12776 · Cited by 29
Piao, L., Park, J., Li, Y., Shin, S., Shin, S., Kong, G., SHRESTHA, R., Tran, Q., Hur, G. M., Kim, J. L., et al. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1693 · Cited by 27
Diet-induced obesity attenuates cytokine production following an immune challenge
Baumgarner, K. M., Setti, S. E., Diaz, C., Littlefield, A. M., Jones, A. C., & Kohman, R. A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.017 · Cited by 27
Disruption of leptin signalling in a mouse model of Alzheimer’s disease
King, A. E., Brain, A., Hanson, K., Dittmann, J., Vickers, J. C., & Fernández-Martos, C. M. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0203-9 · Cited by 27
Effects of cell-type specific leptin receptor mutation on leptin transport across the BBB
Hsuchou, H., Kastin, A. J., Tu, H., Markadakis, E. N., Stone, K. P., Wang, Y., Heymsfield, S. B., Chua, S. C., Obici, S., Magrisso, I. J., et al. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.011 · Cited by 26
DHA reduces hypothalamic inflammation and improves central leptin signaling in mice
Cheng, L., Hu, T., Shi, H., Chen, X., Wang, H., Zheng, K., Huang, X., & Yu, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118036 · Cited by 26
Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain
Wang, L., Cheng, S., Yin, Z., Xu, C., Lu, S., Hou, J., Yu, T., Zhu, X., Zou, X., Peng, Y., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0030-y · Cited by 25
Low Leptin Availability as a Risk Factor for Dementia in Chilean Older People
Cecilia Albala, B., Bárbara Angel, B., Lera, L., Hugo Sánchez, R., Márquez, C., & Fuentes, P. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000447447 · Cited by 25
Leucine supplementation improves leptin sensitivity in high-fat diet fed rats
Yuan, X., Han, S.-F., Zhang, J., Xu, J., & Qin, L. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.27373 · Cited by 24
Son, M., Oh, S., Choi, J., Jang, J. T., Choi, C. H., Park, K. Y., Son, K. H., & Byun, K. (2019) · Nutrients · doi:10.3390/nu11112773 · Cited by 24
Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease
Pedrós, I., Petrov, D., Artiach, G., Abad, S., Ramon‐Duaso, C., Sureda, F. X., Pallàs, M., Beas‐Zárate, C., Folch, J., & Camins, A. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0574-5 · Cited by 23
Sahu, M., Anamthathmakula, P., & Sahu, A. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12266 · Cited by 23
Heldsinger, A., Grabauskas, G., Wu, X., Zhou, S., Lu, Y., Song, I., & Owyang, C. (2014) · Endocrinology · doi:10.1210/en.2013-2095 · Cited by 22
Grizzanti, J., Lee, H., Camins, A., Pallàs, M., & Casadesús, G. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.11.002 · Cited by 21
Liu, J., Mu, S., Zhang, S., Guo, W., Li, Q., Xiao, X., Zhang, J., & Wang, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4801 · Cited by 21
Hayes, J. P., Moody, J. N., Roca, J. G., & Hayes, S. M. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102156 · Cited by 21
Moser, V. A., Christensen, A., Liu, J., Zhou, A. G., Yagi, S., Beam, C. R., Galea, L. A. M., & Pike, C. J. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.016 · Cited by 20
Hosoi, T., & Ozawa, K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00059 · Cited by 19
Jeon, B. T., Kim, K. E., Heo, R. W., Shin, H. J., Yi, C., Hah, Y., Kim, W., Lee, S., & Roh, G. S. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9542-3 · Cited by 18
Ito, Y., Fukui, M., Kanda, M., Morishita, K., Shoji, Y., Kitao, T., Hinoi, E., & Shirahase, H. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.03.001 · Cited by 18
Lin, C.-I., Shen, C.-F., Hsu, T.-H., & Lin, S. (2017) · Nutrients · doi:10.3390/nu9060619 · Cited by 17
Hurley, M. M., Anderson, E. M., Chen, C., Maunze, B., Hess, E. M., Block, M. E., Patel, N., Cooper, Z., McCoy, R., Dabra, T., et al. (2019) · Neuroendocrinology · doi:10.1159/000501337 · Cited by 16
Hypothalamic Leptin Resistance: From BBB to BBSome
López, M. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005980 · Cited by 15
Annweiler, C., Duval, G. T., Cheng, C., Wong, T. Y., Lamoureux, E. L., Miléa, D., & Sabanayagam, C. (2019) · Nutrients · doi:10.3390/nu11030660 · Cited by 14
Wan, Z., Mah, D., Simtchouk, S., Kluftinger, A., & Little, J. P. (2014) · Adipocyte · doi:10.4161/21623945.2014.985020 · Cited by 9
Hexim1, a Novel Regulator of Leptin Function, Modulates Obesity and Glucose Disposal
Dhar-Mascareño, M., Ramirez, S. N., Rozenberg, I., Rouillé, Y., Kral, J. G., & Mascareno, E. J. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1211 · Cited by 9
The Relation of Circulating Levels of Leptin with Cognition in Patients with Alzheimer's Disease
Ülker, M., & Kenangıl, G. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2017.16978 · Cited by 9
Li, J., Dong, W., McCrory, M. A., Szalai, A. J., Yang, G., Li, L., Li, F., & Zhao, A. Z. (2016) · Biochemical Journal · doi:10.1042/bj20151282 · Cited by 8
Obesity, blood pressure and cognitive function: a reply to Waldstein and Katzel
van Boxtel, M. P. J., Baars, L., & Jolles, J. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803558 · Cited by 6
Derkach, K. V., Zakharova, I. O., Romanova, I. V., Zorina, I. I., Михрина, А. Л., & Shpakov, A. O. (2017) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672917060096 · Cited by 6
Possible involvement of 4-hydroxy-2-nonenal in the pathogenesis of leptin resistance in obesity
Hosoi, T., Kuwamura, A., Thon, M., Tsuchio, K., El‐Hafeez, A. A. A., & Ozawa, K. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00080.2018 · Cited by 6
A novel role of the checkpoint kinase ATR in leptin signaling
Ericson, E., Huldt, C. W., Strömstedt, M., & Brodin, P. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.034 · Cited by 4
Flagged first, then by citations
Research works printed but not linked: 2
- Fietta and Delsante (2022, April 27). Focus on Adipokines—PubMed, Available online: https://pubmed.ncbi.nlm.nih.gov/24640423/.
- (2022, April 27). Effect of Body Mass Index on Serum Leptin Levels—PubMed, Available online: https://pubmed.ncbi.nlm.nih.gov/23272432/.
Cited by
Sorted by citations
The role of adipokines in inflammatory mechanisms of obesity
Kirichenko, T. V., Markina, Y. V., Bogatyreva, A. I., Tolstik, T. V., Varaeva, Y. R., & Starodubova, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314982 · Cited by 289
Alzheimer’s disease as type 3 diabetes: understanding the link and implications
Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98
Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms
Feng, Z., Fang, C., Ma, Y., & Chang, J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03104-9 · Cited by 109
Kumar, G., K., P. G., Poornima, D. V., Shantaram, M., & Ranjita, G. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100154 · Cited by 101
Shi, X., Zheng, Y., Cui, H., Zhang, Y., & Jiang, M. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113893 · Cited by 90
Metadata
- Authors
- Flores-Cordero, J. A., Pérez-Pérez, A., Jiménez-Cortegana, C., Alba, G., Flores-Barragán, A., & Sánchez-Margalet, V.
- Affiliations
- Hospital Universitario Virgen Macarena (ES)
- Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Av. Sánchez Pizjuan 4, 41009 Sevilla, Spain
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-05-06
- Volume
- 23
- Issue
- 9
- Pages
- 5202
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9099768
- OpenAlex
- W4229030955
- Cited by
- 212
- References
- 156
- Citations by year
- 2026: 30 · 2025: 64 · 2024: 64 · 2023: 45 · 2022: 9
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- Funders
- PAIDI CTS-151 Junta de Andalucia, Spain
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- obesity, Alzheimer's disease, dementia, leptin, leptin resistance, adipokines, SOCS3, PTP1B, TCPTP, neuroinflammation, mild cognitive impairment, hippocampus, cerebral cortex, hypothalamus, low-grade inflammation
- MeSH terms
- Alzheimer Disease, Humans, Obesity, Risk Factors, Leptin, Receptors, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review